Inflammatory biomarkers and decline in kidney function in the elderly: The Cardiovascular Health Study

Nephrology Dialysis Transplantation

Volumn 25, Issue 1, 2010, Pages 119-124

  Keller, Christopher ^a,b   Katz, Ronit ^c   Sarnak, Mark J ^d   Fried, Linda F ^e   Kestenbaum, Bryan ^f   Cushman, Mary ^g   Shlipak, Michael G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^g UNIVERSITY OF VERMONT   (United States)

Author keywords

Cystatin C; Inflammation; Inflammatory biomarkers; Kidney

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; CYSTATIN C; D DIMER; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PLASMIN; PROCOAGULANT; SERUM ALBUMIN;

AGED; AGING; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GERIATRIC PATIENT; GERIATRICS; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERUM;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KIDNEY; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 72949099846     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp429     Document Type: Article

References (25)

1. Muntner P, Hamm LL, Kusek JW et al. The prevalence of nontradi-tional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004; 140: 9-17
2. Shlipak MG, Fried LF, Crump C et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92
3. Keller CR, Odden MC, Fried LF et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 2007; 71: 239-244
4. Fried L, Solomon C, Shlipak M et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 2004; 15: 3184-3191
5. Tonelli M, Sacks F, Pfeffer M et al. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 2005; 68: 237-245 (Pubitemid 43181381)
6. Rule AD, Larson TS, Bergstralh EJ et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929-937
7. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100
8. Sarnak MJ, Poindexter A, Wang SR et al. Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 2002; 62: 2208-2215
9. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the dade behring N latex cystatin C assay on the dade behring nephelometer II system. Scand J Clin Lab Invest 1999; 59: 1-8
10. Stevens LA, Coresh J, Schmid CH et al. Estimating GFR using serum cystatin c alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406
11. Klein R, Klein BE, Moss SE et al. The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 1999; 22: 743-751
12. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315
13. Levey AS, Coresh J, Balk E et al.National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147
14. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997; 43: 52-58
15. Cushman M, Cornell ES, Howard PR et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 1995; 41: 264-270
16. Jenny NS, Arnold AM, Kuller LH et al. Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults. J Thromb Haemost 2006; 4: 107-113
17. Cushman M, Lemaitre RN, Kuller LH et al. Fibrinolytic activation markers predict myocardial infarction in the elderly: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 493-498
18. Ives DG, Fitzpatrick AL, Bild DE et al. Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study. Ann Epidemiol 1995; 5: 278-285
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
20. Shlipak MG, Katz R, Cushman M et al. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med 2005; 118: 1416
21. Coll E, Botey A, Alvarez L et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000; 36: 29-34
22. Randers E, Erlandsen EJ, Pedersen OL et al. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol 2000; 54: 203-209
23. GoldwasserP, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997; 50: 693-703
24. Cushman M, Arnold AM, Psaty BM et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study. Circulation 2005; 112: 25-31
25. Luc G, Bard JM, Juhan-Vague I et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol 2003; 23: 1255-1261